Company Profile
Yap Inc.
Our mission is to bridge the world and Japan's pharmaceutical and health industries, contributing to people's health worldwide.
Mission / Vision / Values
Mission
Transform pharmaceutical distribution so every patient can access optimal healthcare.
Vision
Become the pharmaceutical distribution hub connecting the world and Japan, bridging healthcare across borders.
Values
Trust, Speed, Transparency. Staying honest to both partners and patients.
History
Mar 2023
Yap Inc. founded. Joined Antler Japan Cohort Program
May 2023
Received pre-seed investment from Antler Japan
Jul 2023
Signed MoU with UniMed UniHealth (Bangladesh)
Dec 2023
Signed import agreement with UniMed UniHealth — first Bangladeshi pharma to enter Japan
Feb 2024
Signed business alliance with Asa Ren (Indonesia) for digital biobank collaboration
Mar 2024
Presented at Antler Japan DEMO DAY
Company Information
- Company Name
- Yap Inc.
- English Name
- Yap Inc.
- Founded
- March 2023
- CEO
- Masaya Yamamoto
- Capital
- ¥37 million (incl. capital reserve)
- Location
- 5-53-67 Jingumae, Shibuya-ku, Tokyo, Cosmos Aoyama South 502
- Business
- Pharmaceutical & health product import/export, distribution management, global expansion support
Access
5-53-67 Jingumae, Shibuya-ku, Tokyo, Cosmos Aoyama South 502
On the west side of Aoyama-dori, across from Aoyama Gakuin University and just behind the UN University.
- Approx. 8 min walk from Omotesando Sta. (Tokyo Metro)
- Approx. 10 min walk from Shibuya Sta. (JR / Tokyo Metro)
CEO Profile
Masaya Yamamoto
CEO & Representative Director
With over 25 years in the pharmaceutical industry, he led system modernization through cloud migration and RPA adoption at pharmaceutical companies, reducing workloads and optimizing costs. Drawing on a deep, first-hand understanding of how the pharmaceutical industry works on the ground, he founded Yap Inc. in 2023.
Today he drives the digital transformation of prescription-drug distribution through the Yap-cloud platform, improving efficiency and transparency across logistics and commercial flows. His aim, together with his team, is to deliver sustainable and innovative solutions that allow pharmaceutical distribution to serve as true social infrastructure. He is also active as a NewsPicks expert in healthcare and pharmaceuticals.